FIA
XBI icon

FNY Investment Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FNY Investment Advisers’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-7,385
Closed -$1.17M – 1027
2026
Q2 		$1.17M Buy
+7,385
New +$998K 0.42% 59
2025
Q4 		– Sell
-15,133
Closed -$1.52M – 1543
2025
Q3 		$1.52M Buy
+15,133
New +$1.36M 0.49% 53
2024
Q3 		– Sell
-10
Closed – – 839
2024
Q2 		$0 Sell
10
-2,882
-100% -$258K ﹤0.01% 843
2024
Q1 		$274K Buy
+2,892
New +$268K 0.17% 105
2023
Q1 		– Sell
-100
Closed -$8K – 760
2022
Q4 		$8K Buy
+100
New +$8.1K 0.01% 327
2022
Q3 		– Sell
-2,000
Closed -$148K – 878
2022
Q2 		$148K Buy
2,000
+1,245
+165% +$93.5K 0.11% 126
2022
Q1 		$67K Buy
+755
New +$69.7K 0.06% 215
2020
Q2 		– Sell
-10,000
Closed -$774K – 614
2020
Q1 		$774K Buy
+10,000
New +$885K 0.59% 43

Other funds holding XBI

Annex Advisory Services
Annex Advisory Services Brookfield, Wisconsin $6.11B AUM 13.75% 1-Year Est. Return
MIRAE ASSET SECURITIES (USA) INC.
MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.78% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return
EWM
Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
AIC
Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return
MWA
MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FA
Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

FNY Investment Advisers's XBI Position: Q3 2026 in Review

FNY Investment Advisers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, closing a stake of 7,385 shares — an estimated $1.17M sold.

FNY Investment Advisers first reported a position in XBI in Q1 2020 and held it in 8 quarters. The position peaked at $1.52M in Q3 2025. 136 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • FNY Investment Advisers reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 7,385 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $1.17M.
  • FNY Investment Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 8 quarters.
  • FNY Investment Advisers's State Street SPDR S&P Biotech ETF position peaked at $1.52M in Q3 2025.
  • 136 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on FNY Investment Advisers's 13F filing for Q3 2026, filed 16 Oct 2026.